IMPROVING CANADA’S PHARMACEUTICAL SUPPLY CHAIN SUSTAINABILITY

A Canadian Manufacturer’s Perspective

To address this critical national security issue, the Canadian Generic Pharmaceutical Association (CGPA) released on June 17 2020 its Blueprint for a Sustainable Supply of Prescription Medicines for Canadians

Pharmascience entirely supports the CGPA Blueprint. The following recommendations are a subset of the broad series recommended by CGPA that, in our opinion, are the likeliest to result in rapid and/or lasting improvements to Canada’s pharmaceutical supply reliability.

Read more